Possible Role for Immunotherapy in Early-Stage Breast Cancer – Medscape
Medscape |
Possible Role for Immunotherapy in Early-Stage Breast Cancer
Medscape CHICAGO — Immune checkpoint blockade may have a role in the presurgery treatment of high-risk, early-stage breast cancers, according to results from a phase 2 trial presented here at the American Society of Clinical Oncology (ASCO) 2017 Annual … |
|
Cardiac stem cells from heart disease patients may be harmful
Science Daily Patients with severe and end-stage heart failure have few treatment options available to them apart from transplants and “miraculous” stem cell therapy. But a new Tel Aviv University study finds that stem cell therapy may, in fact, harm heart disease … |
|
Targeting Immune Cells That Help Tumors Stay Hidden Could Improve Immunotherapy
Newswise (press release) Newswise — Researchers at University of Pittsburgh School of Medicine and UPMC have discovered a clue that could unlock the potential of immunotherapy drugs to successfully treat more cancers. The findings, published in Cell, were made in mice and … |
|
Stem cell therapy may harm heart disease patients, study finds
News-Medical.net Patients with severe and end-stage heart failure have few treatment options available to them apart from transplants and “miraculous” stem cell therapy. But a new Tel Aviv University study finds that stem cell therapy may, in fact, harm heart disease … |
|
Danger in treating cardiac patients with stem cells
San Diego Jewish World TEL AVIV (Press Release) — Patients with severe and end-stage heart failure have few treatment options available to them apart from transplants and “miraculous” stem cell therapy. But a new Tel Aviv University study finds that stem cell therapy may … |